Results 11 to 20 of about 36,882 (246)

Intrinsic Fluorescence of PAMAM Dendrimers—Quenching Studies [PDF]

open access: yesPolymers, 2018
Intrinsic, non-traditional fluorescence of polyamidoamine (PAMAM) dendrimers that do not possess classical fluorophores has been attracting considerable interest for the last decade. Many hypotheses regarding the source of the fluorescence have appeared, but some of them are still disputable.
Malgorzata Konopka   +2 more
europepmc   +4 more sources

Selective Cellular Uptake and Druggability Efficacy through Functionalized Chitosan-Conjugated Polyamidoamine (PAMAM) Dendrimers [PDF]

open access: yesSensors
Nanotechnology has ushered in significant advancements in drug design, revolutionizing the prevention, diagnosis, and treatment of various diseases. The strategic utilization of nanotechnology to enhance drug loading, delivery, and release has garnered ...
Ye Hu, Jian Chen, Wenyan Hu
doaj   +3 more sources

Inverse Polyamidoamine (i‐PAMAM) Dendrimer Antimicrobials [PDF]

open access: yesHelvetica Chimica Acta, 2023
AbstractHere we redesigned the branches of polyamidoamine (PAMAM) dendrimers by moving the amide carbonyl group on the other side of the amide nitrogen atom, transforming the β‐alaninyl‐amidoethylamine branch, which easily undergoes retro‐Michael reactions and renders PAMAMs intrinsically unstable, into a more stable glycyl‐amidopropylamine branch. The
Bonvin, Etienne, Reymond, Jean-Louis
openaire   +3 more sources

Curcumin encapsulated in PAMAM dendrimers for the therapeutic treatment of ischemic stroke in rats [PDF]

open access: yesFrontiers in Cell and Developmental Biology
IntroductionIschemic stroke is a devastating neurovascular condition that occurs when cerebral tissue fails to receive an adequate supply of oxygen. Despite being a leading cause of death and disability worldwide, therapeutic interventions are currently ...
Justin Stadler   +25 more
doaj   +2 more sources

Hydrogel of Ketoconazole and PAMAM Dendrimers: Formulation and Antifungal Activity

open access: yesMolecules, 2012
Ketoconazole (KET), an imidazole derivative with well-known antifungal properties, is lipophilic and practically insoluble in water, therefore its clinical use has some practical disadvantages.
Elzbieta Tryniszewska   +4 more
doaj   +2 more sources

High Fluorescent Porphyrin-PAMAM-Fluorene Dendrimers [PDF]

open access: yesMolecules, 2015
Two new classes of dendrimers bearing 8 and 32 fluorene donor groups have been synthesized. The first and second generations of these porphyrin-PAMAM-fluorene dendrimers were characterized by 1H-NMR, 13C-NMR, FTIR, UV-vis spectroscopy, elemental analyses and MALDI-TOF mass spectrometry.
Karla Garfias-Gonzalez   +6 more
openaire   +4 more sources

New Advances in General Biomedical Applications of PAMAM Dendrimers [PDF]

open access: yesMolecules, 2018
Dendrimers are nanoscopic compounds, which are monodispersed, and they are generally considered as homogeneous. PAMAM (polyamidoamine) was introduced in 1985, by Donald A. Tomalia, as a new class of polymers, named ‘starburst polymers’.
Renan Vinícius de Araújo   +3 more
semanticscholar   +2 more sources

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment? [PDF]

open access: yesPharmaceutics, 2023
Based on their drug delivery properties and activity against tumors, we combined PAMAM dendrimers with various platinum(IV) complexes in order to provide an improved approach of anticancer treatment.
Yvonne Lerchbammer-Kreith   +6 more
doaj   +2 more sources

PAMAM dendrimers as efficient drug nanocarriers of natural compounds in breast cancer therapeutics [PDF]

open access: yesFrontiers in Oncology
Breast cancer is among the most prevalent cancers in women and leads to significant mortality worldwide. It remains a global health issue, affecting millions of women annually despite progress in diagnosis and treatment.
Syed Gulfishan   +7 more
doaj   +2 more sources

PAMAM dendrimers: blood‐brain barrier transport and neuronal uptake after focal brain ischemia [PDF]

open access: yesJournal of Controlled Release, 2018
Drug delivery to the central nervous system is restricted by the blood‐brain barrier (BBB). However, with the onset of stroke, the BBB becomes leaky, providing a window of opportunity to passively target the brain. Here, cationic poly(amido amine) (PAMAM)
S. Santos   +10 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy